Skip to main content
. Author manuscript; available in PMC: 2018 Nov 28.
Published in final edited form as: Circulation. 2017 Oct 4;136(22):2162–2177. doi: 10.1161/CIRCULATIONAHA.117.029557

Figure 2. CTRP9 increased ADSCs survival in peri-infarct area 1 and 3 days after MI.

Figure 2

A. Representative images of EGFP-ADSCs in hearts 1 and 3 days after MI. Heart tissue was immunostained for GFP (green), DAPI (blue), and Troponin T (red). B. Quantification of EGFP-ADSCs in the peri-infarct area was determined by the number of GFP-positive cells per total nuclei. n=20 from 4 mice. C. ADSCs engraftment was quantified as the number of GFP-positive cells per 100 heart cells in apex region. n=4 mice. Data are mean ± SEM. *P<0.05 vs. WT MI+ADSC+vehicle. Statistical significance was determined with two-way ANOVA followed by Bonferroni post-hoc test.